New Pill for Alopecia-Related Hair Loss Approved by FDA

Medicine & Technology Jun 15, 2022

The Food and Drug Administration recently approved the first-ever drug against alopecia. Read more about the treatment and how it works.

New COVID Study Shows Arthritis Drug, Baricitinib, Reduces Recovery Time for Adults

Dec 14, 2020

Hospitalized adults treated with an arthritis drug called baricitinib, in addition to COVID treatment programs, are found to recover faster, even in more serious cases of the highly contagious disease.

Montefiore and Einstein College Introduce Trials for Remdesivir-Baricitinib Combo as a Treatment Option for COVID-19

May 27, 2020

Montefiore Health System and Albert Einstein College of Medicine have begun with ACTT 2, a clinical trial using the drug combination remdesivir and baricitinib to treat patients with COVID-19. Researchers are hoping the new drug combo would reduce COVID-19-related inflammation and provide better recovery outcomes for coronavirus patients.